Inventiva annonce sa participation à la H.C. Wainwright 20th Annual Global Investment Conference
August 29, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Inventiva announces that it has been informed of the modification of the call option agreement concluded by BVF Partners L.P.
August 22, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva announces that it has been...
Inventiva annonce avoir été informée de la modification du contrat d'option conclu par BVF Partners L.P.
August 22, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Inventiva's lanifibranor found to have good safety profile following first assessment of carcinogenicity studies' results
August 13, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Une analyse préliminaire des résultats des études de carcinogénicité avec lanifibranor d'Inventiva met en évidence un bon profil de sécurité
August 13, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Inventiva to Present the Latest Findings in its RORy program at the 256th National Meeting of the American Chemical Society
August 01, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva to Present the Latest...
Inventiva présentera les derniers résultats de son programme RORy lors de la 256ème réunion nationale de l'American Chemical Society
August 01, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva présentera les derniers...
Inventiva Announces Poster Presentation on a Promising Biomarker for MPS VI at the 15th International Symposium on MPS and Related Diseases
July 26, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva Announces Poster...
Inventiva annonce une presentation par affiche concernant un biomarquer prometteur dans la MPS VI lors du 15ème « International Symposium on MPS and Related Diseases »
July 26, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva annonce une presentation par...
Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update
July 19, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva Reports First-half 2018...